Oncotelic Therapeutics Inc
OTC:OTLC
Oncotelic Therapeutics Inc
Minority Interest
Oncotelic Therapeutics Inc
Minority Interest Peer Comparison
Competitive Minority Interest Analysis
Latest Figures & CAGR of Competitors
Company | Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Oncotelic Therapeutics Inc
OTC:OTLC
|
Minority Interest
-$518.6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Minority Interest
$40m
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Minority Interest
-$84m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Oncotelic Therapeutics Inc's Minority Interest?
Minority Interest
-518.6k
USD
Based on the financial report for Dec 31, 2023, Oncotelic Therapeutics Inc's Minority Interest amounts to -518.6k USD.
What is Oncotelic Therapeutics Inc's Minority Interest growth rate?
Minority Interest CAGR 1Y
-136%
Over the last year, the Minority Interest growth was -136%.